Sage Therapeutics to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019
July 11 2019 - 06:30AM
Business Wire
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company
developing novel medicines to treat life-altering central nervous
system (CNS) disorders, today announced it will host a live webcast
on Tuesday, August 6, 2019 at 8:00 a.m. EDT to report its second
quarter 2019 financial results and discuss recent business
updates.
The webcast can be accessed on the investor page of Sage's
website at investor.sagerx.com. A replay of the webcast will be
available approximately two hours after the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel medicines
to transform the lives of patients with life-altering central
nervous system (CNS) disorders. Sage’s portfolio of novel compounds
targets critical receptor systems in the brain and includes the
first treatment specifically approved by the U.S. Food and Drug
Administration for postpartum depression as well as compounds being
developed as potential treatments for diseases such as major
depressive disorder, insomnia, bipolar disorder and essential
tremor. For more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190711005150/en/
Investor Contact Maren Killackey 617-949-4113
maren.killackey@sagerx.com
Media Contact Alexis Smith 617-588-3740
alexis.smith@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2023 to Mar 2024